Skip to main content
. 2014 Sep;6(9):1319–1328. doi: 10.3978/j.issn.2072-1439.2014.07.15

Table 2. Mechanisms of CDC strips involved multi-pathways and multi-targets.

Mechanisms of CDC strips Pathways and targets
Organ & tissue-based (e.g., vascular-specific) Lifestyles risk factors (Table 1):
→ Immunity function (–)
→ Acute or chronic inflammation
→ Vascular endothelial cells (VEC) injure
→ Vascular injure
→ AS or stiff or rupture
→ Ischemia or oxygen not enough
→ Microcirculation dysfunction
→ Organ or tissue injure
→ NCDs (CVD, DM, cancer, even CDC strips)
→ Others
Cell-based Internal or external stimuli → inflammation
Cells including: TAM, mast cells, dendritic cells, NK cells, neutrophils, eosinophils and lymphocytes
Cytokines, chemokines, transcription factors, etc: (+)
Including: ROS & RNS, MMP, TNF, IL-1, I-L6, IL-8, IFNs, NF-κB, etc.
Enzymes, such as COX-2, LOX-5, PLA2, etc.
Biomarkers, such as vitamin D, Vit E and Vit C levels, hs-CRP, MAU, Hcy, Homocysteine, CA125, CA19-9, and CA153, etc.
Signals, such as SMAD, STAT3, AMPK, etc.
Apoptosis
Telomerase
(+) CSC and (–) adults SC (46)
Others, such as eicosanoid, kinins, etc.
Gene-based A positive family history
Genetic variants
Gene mutation
DNA repair
DNA methylation
Micro-RNA
Others: P53, Bcl-2, etc.

Lifestyles risk factors (showed in Table 1) mean “Bad SEED”; genetic risk factors mean “bad soil”. The shared “Bad SEED”+/– “bad soil” leading to “internal environment injure, abnormal, or unbalance” [e.g., (+) CSC and/or (–) adults SC?] may explain the mechanisms of CDC strips involved multi-pathways and multi-targets. Here, - means decrease or inactivate; + means increase or activate. TAM, tumor-associated macrophages; NK, natural killer; ROS, reactive oxygen; RNS, nitrogen species; MMP, matrix metalloproteinase; TNFα, tumor necrosis factor α; CVD, cardiovascular disorder; DM, diabetes mellitus; CRP, C-reactive protein; NcDs, non-communicable diseases; interleukins (IL-1, IL-6, IL-8), interferon (IFNs), cyclooxygenase-2 (COX-2), lipooxygenase-5 (LOX-5), phospholipase A2 (PLA2), transcription factors nuclear factor κB (NF-κB); STAT3, signal transducers and activators of transcription-3; CSC, cancer stem cell.